According to experts, a baby born today has a 40 per cent chance of living for 150 years, largely due to advances in medical technology ...
Phase 3 AQUILA study showed DARZALEX FASPRO® significantly reduced the risk of progression to active multiple myeloma or death by 51 percent compared to ...